Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1Phase 3 1Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 3Thoracic 1Sarcoma 1Other 1Head & Neck 1Genitourinary 1Gastrointestinal 1

Conditions

Mucositis 44Obesity 23Neoplasms 19Head and Neck Neoplasms 15Stomatitis 12Dyspnea 12Constipation 10Sexual Dysfunction, Physiological 8Squamous Cell Carcinoma of Head and Neck 7Breast Neoplasms 7Overweight 6Xerostomia 5Prostatic Neoplasms 5Radiation Injuries 4Opioid-Induced Constipation 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Polycystic Ovary Syndrome 3Pain 3Nausea 3Mouth Neoplasms 3Hematologic Neoplasms 3Colorectal Neoplasms 3Tongue Neoplasms 2Salivary Gland Neoplasms 2Multiple Myeloma 2Mouth Diseases 2Leukemia 2Intestinal Diseases 2Infertility 2Febrile Neutropenia 2

Interventions

alvimopan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Cancer Pain × Other × Clear all
NCT00101998 2017-08-30

Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Phase 2 Completed
233 enrolled
Other

Cancer Pain, Constipation, Intestinal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡